|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of spironolactone on endothelial function,vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment显示文摘 | MACDONALD J E KENNEDY N STRUTHERS A D | 2004 | Heart2004，90，： | 1 |
| 2 | A randomized comparative study of the prophylactic use of trimethoprim-sulfamethoxazole versus netilmycin-metronidazole in transrectal prostatic biopsy显示文摘 | Fong I W Struthers N Honey RJ | 1991 | J Urol1991，146，3： | 1 |
| 3 | QT dispersion and tripple-vessel coronary disease显示文摘 | Struthers A D Davidson N C Naas A | 1997 | Lancet1997，349，： | 1 |
| 4 | Brain natriuretic pepide 显示文摘 | 1)avidson N C Struthers A D | 1994 | J Hypertens1994，12，4： | 1 |
| 5 | Anaemia in chronic heart failure:what is its frequency in the UK and its underlying causes显示文摘 | Cromie N Lee C Struthers A D | 2002 | Heart2002，87，4： | 1 |
| 6 | Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? 显示文摘 | Cromie N Lee C Struthers A | 2002 | Heart2002，87，4： | 1 |
| 7 | Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment 显示文摘 | Macdonald JE Kennedy N Struthers AD | 2004 | Heart2004，90，7： | 1 |
| 8 | Effects of spironolactone on endothelial function , vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment显示文摘 | Macdonald JE Kennedy N Struthers AD | 2004 | Heart2004，90，： | 1 |
| 9 | 显示文摘 | Cromie N Lee C Struthers AD | 2002 | Heart2002，87，4： | 1 |
| 10 | Effects of spironolactone on endothelial function,vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment显示文摘 | Macdonald JE Kennedy N Struthers AD | 2004 | Heart2004，90，7： | 1 |
| 11 | Effects of spironolactone on endothelial function,vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment显示文摘 | Macdonald JE Kennedy N Struthers AD | 2004 | Heart2004，90，： | 1 |
| 12 | Brain natfiuretic peptide 显示文摘 | DAVIDSON N C STRUTHERS A D | 1994 | Hypertens1994，12，： | 1 |
| 13 | QT dispersion and tripple-vessel coronary disease显示文摘 | Struthers A D Davidson N C Naas A | 1997 | Lancet1997，349，： | 1 |
| 14 | Anaemia in chronic heart failure:what is its frequency in the UK and its underlying causes显示文摘 | Cromie N Lee C Struthers AD | 2002 | Heart2002，87，： | 1 |
| 15 | Anaemia in chronic heart failure: what is its frequency in the Uk and its underlying causes 显示文摘 | Cromie N Lee C Struthers AD | 2002 | Heart2002，87，4： | 1 |
| 16 | Anaemia in chronic heart failure: what is its frequency in the UK and its underlying cause 显示文摘 | Cromie N Lee C Struther AD | 2002 | Heart2002，87，4： | 1 |
| 17 | Effects of spironolactone on endothelial function,vascular angiotesin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment显示文摘 | Kennedy N Struthers AD | 2004 | Heart2004，90，7： | 1 |
| 18 | Anaemia in chronic heart failure:what is its frequency in the UK and its underlying cause 显示文摘 | Cromie N Lee C Struthers AD | 2002 | Heart2002，87，： | 1 |
| 19 | Effects of spironolactone on endothelial function,vascular angiotensin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment显示文摘 | Macdonald JE Kennedy N Struthers AD | 2004 | Heart2004，90，7： | 1 |
| 20 | Anaemia in chronic heart failure:What is its frequency in the UK and its underlying cause?显示文摘 | CROMIE N LEE C STRUTHERS A D | 2002 | Heart2002，87，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员